US: AIHLF - Adcock Ingram Holdings Limited

半年間の収益性: 0%

プロモーションスケジュール Adcock Ingram Holdings Limited


会社について

Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. It operates through four divisions: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services.

さらに詳しく
The company is involved in the sale of various healthcare, personal care, and homecare products through FMCG retailers and corporate pharmacies; OTC medicinal products through corporate and independent pharmacies; branded and generic prescription products, and specialized instrumentation and surgical products; and hospital products and services. It offers its products for allergies, antiretroviral, baby care, cardiovascular, cannabidiol, central nervous system, colds and flu, cough, dermatology, digestive well-being, energy, feminine hygiene, food and nutrition supplements, gastroenterology, generics, ophthalmology, pain, personal care, respiratory, vitamins, minerals supplements, and women's health. The company also provides critical care products, including intravenous solutions, blood collection products, and renal dialysis systems. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.

EBITDA 17.94
EV/EBITDA 0.6991
Industry Pharmaceuticals
P/BV 0.161
P/E 1.08
P/S 0.0994
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 127.25
Див.доход ао 172.18
Дивиденд ао 1.59
Сайт https://www.adcock.co.za
Цена ао 2.45
Число акций ао 0.15463 млрд
1日あたりの価格変動: 0% (2.45)
週ごとの価格変動: 0% (2.45)
月ごとの料金変更: 0% (2.45)
3ヶ月間の価格変動: 0% (2.45)
半年間の価格変動: 0% (2.45)
年間の価格変動: 0% (2.45)
3年間の価格推移: -21.97% (3.14)
5年間の価格推移: -43.16% (4.31)
10年間の価格推移: 0% (2.45)
年初からの価格変動: 0% (2.45)

過小評価

名前 意味 学年
P/S 0.7119 10
P/BV 0.0703 10
P/E 8.43 9
EV/EBITDA 7.25 9
合計: 8.63

効率

名前 意味 学年
ROA, % 1.02 1
ROE, % 1.58 1
合計: 1.67

配当金

名前 意味 学年
Div yield, % 166.72 10
DSI 0.8571 8.57
合計: 8.51

義務

名前 意味 学年
Debt/EBITDA 3.55 3
合計: 5.8

成長の衝動

名前 意味 学年
収益性 Revenue, % -92.9 0
収益性 Ebitda, % -92.56 0
収益性 EPS, % 20.99 4
合計: 0.8

スーパーバイザー 役職 支払い 生年
Mr. Andrew Gideon Hall CA (SA), BPharm CEO & Executive Director 1962 (63 年)
Ms. Dorette Neethling CFO & Executive Director 1974 (51 年)
Ms. Basadifeela Letsoalo Executive Director of Transformation & Human Capital and Executive Director 1963 (62 年)
R. Essa Corporate Finance Director
Mr. Mahlatse Phalafala Company Secretary & Head of Legal
Mr. Nkosinathi Mthethwa Public Affairs Executive
Mr. Ashley Pearce Dip. Pharm, BCom Managing Director of Prescription
Mr. Colin Sheen B.Tech., M.B.A., NDip Mktg, PDBA Managing Director of Hospital
Mr. Tobie Krige MBA Managing Director of Distribution
Mr. Azhar Kaka Head of Sales - Consumer Division

住所: South Africa, Midrand, 1 New Road - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.adcock.co.za